Economist
-
Health News
Part 3 – Healthcare Economist
See my previous posts on IRA price negotiation on drug selection (Part 1) and manufacturer data submission (Part 2). Today…
Read More » -
Health News
Part 1 – Healthcare Economist
CMS released guidance on IRA price negotiation last week. Below are some highlights regarding how drugs will be selected. Which…
Read More » -
Health News
Risk Adjustment and Incentives for Upcoding in Medicare – Healthcare Economist
To account for differences in disease burden across a Medicare Advantage (MA) plans patient population, uses risk adjustment based on…
Read More » -
Health News
FDA’s Biosimilars Action Plan – Healthcare Economist
In July 2018, FDA released the Biosimilars Action Plan (BAP), which outlined FDA’s approach for…
Read More » -
Health News
15 Year Anniversary of The Healthy Home Economist!
Today marks the 15th anniversary of my very first post on The Healthy Home Economist blog. 🥳 What a ride…
Read More » -
Health News
Do patients value improvements in progression-free survival? – Healthcare Economist
Progression-free survival (PFS) is a surrogate endpoint is defined as follows (by ChatGPT): In essence, PFS refers to the length…
Read More » -
Health News
What would happen if we eliminated medical debt? – Healthcare Economist
Medical debt in the U.S. is a major problem. While over 90% of individuals have…
Read More » -
Health News
Biosimilar Market Report – Healthcare Economist
Samsung Bioepis has a Biosimilar Market Report for Q2 2024. Some key highlights: As of…
Read More » -
Health News
Traditional Refried Beans | Healthy Home Economist
Table of Contents[Hide][Show] Refried beans recipe using traditional preparation methods and healthy fat for a delicious and easily digested dish…
Read More » -
Health News
EMA and delays in drug launch – Healthcare Economist
For patients with serious illnesses, timeline access to efficacious medications is paramount. The European Medicines Agency (EMA) was created in…
Read More »